COMT Inhibition Among Individuals With Comorbid AUD/ADHD

NCT03904498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Alcohol Use Disorder
Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Tolcapone
DRUG: Placebo

Sponsor

University of Colorado, Denver

Collaborators

[object Object]